Naoka Murakami, MD, PhD

Nephrology, Transplant Nephrology

Naoka Murakami

Appointment Options

Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you.

My Locations

Gary C. Werths Building at Siteman Cancer Center

Gary C. Werths Building at Siteman Cancer Center

On WashU Medicine Campus
4500 Forest Park Avenue, Saint Louis, MO 63108
Center for Advanced Medicine

Center for Advanced Medicine

On WashU Medicine Campus
4921 Parkview Place, Saint Louis, MO 63110

Expertise & Training

Clinical Expertise

  • Nephrology, Transplant Nephrology

Primary Academic Title

Assistant Professor, Department of Medicine, Division of Nephrology, WashU Medicine

Board Certification

  • 2015: American Board of Internal Medicine
  • 2019: American Board of Internal Medicine

Training

  • 2010 - 2012: Resident-Medicine, Toranomon Hospital, Tokyo, Japan
  • 2012 - 2015: Resident-Medicine, Mount Sinai Beth Israel, New York, NY
  • 2015 - 2019: Fellow, Joint Nephrology Fellowship Program, Brigham and Women's Hospital, Massachusetts General Hospital, Boston, MA
  • 2019 - 2020: Transplant, Brigham and Women's Hospital, Massachusetts General Hospital, Boston, MA

Education

  • 2009: PhD, University of Tokyo, Japan
  • 2010: MD, University of Tokyo, Japan

Research & Selected Publications

Research Interest

Immune checkpoint blockade-associated kidney injury, immunotherapy in solid organ transplant recipients, cancers post-kidney transplant, kidney transplant for patients with plasma cell dyscrasia (myeloma, AL amyloidosis, monoclonal gammopathy with renal significance)

Research Publications

The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup
Authors:

Renaghan AD, Ostermann M, Ronco C, one or more additional authors omitted Murakami N, one or more additional authors omitted Rosner MH

Journal & Year:

Nat Rev Nephrol | 2026

Immunotherapy and Cellular Therapies for Cancers in Kidney Transplant Patients
Authors:

Merzkani M, Attieh RM, Jhaveri KD, Murakami N

Journal & Year:

Am J Nephrol | 2026

Management recommendations for kidney transplantation in patients with plasma cell dyscrasia
Authors:

Murakami N, Blosser CD, Webber AB, one or more additional authors omitted Landau H

Journal & Year:

Kidney Int | 2025

Outcomes of Solid Organ Transplant Recipients With Advanced Cancers Receiving Immune Checkpoint Inhibitors: A Systematic Review and Individual Participant Data Meta-Analysis
Authors:

Saleem N, Wang J, Rejuso A, one or more additional authors omitted Murakami N, Wong G

Journal & Year:

JAMA Oncol | 2025